State of Alaska Department of Revenue’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,710
Closed -$252K 1612
2023
Q2
$252K Sell
9,710
-294
-3% -$7.63K ﹤0.01% 1574
2023
Q1
$287K Sell
10,004
-169
-2% -$4.85K ﹤0.01% 1550
2022
Q4
$301K Buy
10,173
+65
+0.6% +$1.92K ﹤0.01% 1541
2022
Q3
$240K Sell
10,108
-76
-0.7% -$1.81K ﹤0.01% 1561
2022
Q2
$227K Buy
10,184
+140
+1% +$3.12K ﹤0.01% 1578
2022
Q1
$252K Sell
10,044
-180
-2% -$4.52K ﹤0.01% 1563
2021
Q4
$366K Sell
10,224
-300
-3% -$10.7K ﹤0.01% 1548
2021
Q3
$447K Buy
10,524
+570
+6% +$24.2K ﹤0.01% 1504
2021
Q2
$430K Buy
9,954
+230
+2% +$9.94K ﹤0.01% 1496
2021
Q1
$396K Sell
9,724
-1,340
-12% -$54.6K ﹤0.01% 1499
2020
Q4
$500K Sell
11,064
-2,230
-17% -$101K 0.01% 1353
2020
Q3
$470K Buy
13,294
+230
+2% +$8.13K 0.01% 1265
2020
Q2
$492K Sell
13,064
-170
-1% -$6.4K 0.01% 1248
2020
Q1
$382K Buy
13,234
+2,455
+23% +$70.9K 0.01% 1223
2019
Q4
$558K Buy
10,779
+191
+2% +$9.89K 0.01% 1259
2019
Q3
$581K Buy
10,588
+5,751
+119% +$316K 0.01% 1194
2019
Q2
$196K Buy
4,837
+50
+1% +$2.03K ﹤0.01% 1459
2019
Q1
$144K Buy
4,787
+35
+0.7% +$1.05K ﹤0.01% 1537
2018
Q4
$159K Sell
4,752
-110
-2% -$3.68K ﹤0.01% 1481
2018
Q3
$205K Buy
4,862
+40
+0.8% +$1.69K ﹤0.01% 1497
2018
Q2
$154K Buy
4,822
+90
+2% +$2.87K ﹤0.01% 1539
2018
Q1
$235K Buy
4,732
+1,830
+63% +$90.9K ﹤0.01% 1347
2017
Q4
$156K Hold
2,902
﹤0.01% 1389
2017
Q3
$168K Buy
2,902
+30
+1% +$1.74K 0.01% 1064
2017
Q2
$141K Buy
2,872
+1,272
+80% +$62.4K 0.01% 999
2017
Q1
$69K Hold
1,600
0.01% 1049
2016
Q4
$78K Buy
+1,600
New +$78K 0.01% 730